91968-71-7

Basic information

• Product Name: 2-BENZYLOXY-2-METHYLPROPAN-1-OL
• Synonyms: 2-BENZYLOXY-2-METHYLPROPAN-1-OL;2-Benzyloxy-2-methyl-1-propanol, 95%
• CAS NO: 91968-71-7
• Molecular Formula: C₁₁H₁₆O₂
• Molecular Weight: 180.24
• Mol File: 91968-71-7.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 62-65°C/1mm
• Flash Point: 80-85°C/0.1mm
• Appearance: /
• Density: 1.025g/cm³
• Vapor Pressure: 0.00266mmHg at 25°C
• Refractive Index: 1.514
• PKA: 15.18±0.10(Predicted)
• Water Solubility: Immiscible with water.
• CAS DataBase Reference: 2-BENZYLOXY-2-METHYLPROPAN-1-OL(CAS DataBase Reference)
• NIST Chemistry Reference: 2-BENZYLOXY-2-METHYLPROPAN-1-OL(91968-71-7)
• EPA Substance Registry System: 2-BENZYLOXY-2-METHYLPROPAN-1-OL(91968-71-7)

Safety Data

• Hazard Codes: Xi
• HazardClass: IRRITANT
• Hazardous Substances Data: 91968-71-7(Hazardous Substances Data)

Usage

Description

2-Benzyloxy-2-methylpropan-1-ol is an organic compound that serves as a versatile building block in organic synthesis, characterized by its benzyloxy and methylpropan-1-ol functional groups.

Uses

Used in Organic Synthesis:
2-Benzyloxy-2-methylpropan-1-ol is used as a building block in organic synthesis for the creation of various complex organic molecules. Its unique structure allows for the formation of a wide range of compounds with diverse applications.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-Benzyloxy-2-methylpropan-1-ol is used as a key intermediate in the synthesis of heterocyclic compounds. These heterocyclic compounds are essential in the development of new drugs with potential therapeutic properties.
Used in Chemical Research:
2-Benzyloxy-2-methylpropan-1-ol is also utilized in chemical research for the exploration of new synthetic pathways and the development of innovative chemical reactions. Its reactivity and functional groups make it a valuable tool for advancing the field of organic chemistry.

InChI:InChI=1/C11H16O2/c1-11(2,9-12)13-8-10-6-4-3-5-7-10/h3-7,12H,8-9H2,1-2H3

Upstream product

• 87122-87-0 2-(benzyloxy)-2-methylpropanoic acid 
• 100-39-0 benzyl bromide 
• 100-51-6 benzyl alcohol 
• 347400-73-1 benzyl 2-(benzyloxy)-2-methylpropanoate 
• 87122-86-9 2-benzyloxy-2-methylpropanoic acid methyl ester 

Downstream Products

• 145486-31-3 2-(benzyloxy)-2-methylpropanal 
• 1217401-28-9 2-[2-(benzyloxy)-2-methylpropoxy]-N-{(3E)-5-tert-butyl-1-methyl-2-[(2R)-tetrahydrofuran-2-ylmethyl]-1,2-dihydro-3H-pyrazol-3-ylidene}-5-(trifluoromethyl)benzamide 
• 558-43-0 2-Methyl-1,2-propanediol 

Relevant articles and documents

METHODS OF CULTURING AND/OR EXPANDING STEM CELLS AND/OR LINEAGE COMMITTED PROGENITOR CELLS USING AMIDO COMPOUNDS

Provided are methods for expanding stem cells and/or lineage committed progenitor cells, such as hematopoietic stems cells and/or lineage committed progenitor cells, at least in part, by using compounds that antagonize AhR. The compounds are represented by formulae (I) (II) (III) (IV), wherein the letters and symbols a, b, c, d, e, f, g, Z, R1b, R2a and R2b have the meanings provided in the specification. Also provided are compositions comprising stem cells and/or lineage committed progenitor cells expanded by methods disclosed herein and methods for the treatment of diseases treatable by same.

EXTERNALLY MASKED NEOPENTYL SULFONYL ESTER CYCLIZATION RELEASE PRODRUGS OF ACAMPROSATE, COMPOSITIONS THEREOF, AND METHODS OF USE

Masked nitrogen-substituted and oxygen-substituted neopentyl sulfonyl ester prodrugs of acamprosate, pharmaceutical compositions comprising such prodrugs, and methods of using such prodrugs and compositions thereof for treating diseases are disclosed. In particular, acamprosate prodrugs exhibiting enhanced oral bioavailability and methods of using acamprosate prodrugs to treat neurodegenerative disorders, psychotic disorders, mood disorders, anxiety disorders, somatoform disorders, movement disorders, substance abuse disorders, binge eating disorder, cortical spreading depression related disorders, tinnitus, sleeping disorders, multiple sclerosis, and pain are disclosed.